Hazardous Drug Sample Analysis
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT942726QE008
NAICS
541380 - Testing Laboratories and Services
Classification Code
Q301
Additional Details
The Defense Health Agency (DHA), operating under the Department of Defense, has issued an award notice for the procurement of Hazardous Drug Sample Analysis services. This contract is classified under NAICS code 541380, which pertains to Testing Laboratories and Services, and is further identified by Product Service Code Q301. The primary place of performance for this contract is Aberdeen, Maryland.
The purpose of this procurement is to secure specialized laboratory analysis services for hazardous drug samples. The scope of work likely encompasses the collection, handling, and analytical testing of hazardous drug samples to ensure compliance with safety standards and regulatory requirements, supporting the DHA’s mission to safeguard the health and safety of personnel potentially exposed to hazardous pharmaceuticals. The intended outcome is to obtain accurate, reliable analytical data that informs risk assessments, exposure monitoring, and the implementation of appropriate safety controls within DHA facilities.
Key requirements for this contract include the provision of comprehensive laboratory testing services by a qualified contractor with demonstrated expertise in hazardous drug analysis. The contractor is expected to deliver timely and precise analytical results, adhering to all applicable federal, state, and agency-specific protocols. Deliverables will likely include detailed laboratory reports, data interpretation, and possibly recommendations for mitigating exposure risks based on the findings.
This procurement is not subject to any set-aside restrictions, indicating that it is open to all qualified vendors without limitations for small businesses or other socioeconomic categories. The contract is managed by the Defense Health Agency, with the primary point of contact being Jennifer Bassett ([email protected], 301-619-2268) and a secondary contact, Jessica E. Greene ([email protected], 301-619-7433), both of whom are available for inquiries regarding the contract’s scope and requirements.
Contractors considering this opportunity should possess robust laboratory capabilities, experience with hazardous drug analysis, and a strong track record of compliance with federal testing standards. The contract’s location in Aberdeen, Maryland, and its classification under testing laboratory services, suggest a need for proximity or the ability to efficiently manage sample logistics to and from the site.
This award notice remains active as of the posting date and is accessible via the official SAM.gov portal (Opportunity ID: 80b15e80f37e4928973d7450cce26a2d). Interested parties are encouraged to review the notice in detail and reach out to the designated contacts for further information regarding ongoing or future requirements related to hazardous drug sample analysis for the Defense Health Agency.